The value of QuantiFERON®TB-Gold in the diagnosis of tuberculosis among dialysis patients

Nephrology Dialysis Transplantation

Volumn 24, Issue 7, 2009, Pages 2252-2257

  Inoue, Tsuyoshi ^a   Nakamura, Taichi ^a   Katsuma, Ai ^a   Masumoto, Shoichi ^a   Minami, Eri ^a   Katagiri, Daisuke ^a   Hoshino, Taro ^a   Shibata, Maki ^a   Tada, Manami ^a   Hinoshita, Fumihiko ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Diagnosis; Dialysis; Extrapulmonary TB; QuantiFERON; Tuberculosis

Indexed keywords

ADULT; AGED; ARTICLE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HEMODIALYSIS PATIENT; HUMAN; LEUKOCYTE COUNT; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUBERCULOUS LYMPHADENITIS; TUBERCULOUS PLEURISY; BLOOD; BLOOD EXAMINATION; RENAL REPLACEMENT THERAPY; TUBERCULOSIS;

GAMMA INTERFERON;

AGED; FEMALE; HEMATOLOGIC TESTS; HUMANS; INTERFERON-GAMMA; MALE; RENAL DIALYSIS; TUBERCULOSIS;

EID: 67651115855     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp030     Document Type: Article

References (27)

1. Kang YA, Lee HW, Hwang SS et al. Usefulness of whole-blood interferon-γ enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest 2007; 132: 959-965
2. Wauters A, Peetermans WE, Van Den Brande P et al. The value of tuberculin skin testing in haemodialysis patients. Nephrol Dial Transplant 2004; 19: 433-438
3. Habesoglu MA, Torun D, Demiroglu YZ et al. Value of the tuberculin skin test in screening for tuberculosis in dialysis patients. Transplant Proc 2007; 39: 883-886
4. Passalent L, Khan K, Richardson R et al. Detecting latent tuberculosis infection in hemodialysis patients: a head-to-head comparison of the T-SPOT.TB test, and an expert physician panel. Clin J Am Soc Nephrol 2007; 2: 68-73
5. Hussein MM, Mooij JM, Roujouleh H. Tuberculosis and chronic renal disease. Semin Dial 2003; 16: 38-44
6. Winthrop KL, Nyendak M, Calvet H et al. Interferon-γ release assays for diagnosing Mycobacterium tuberculosis infection in renal dialysis patients. Clin J Am Soc Nephrol 2008; 3: 1357-1363
7. Ravn P, Munk ME, Andersen AB et al. Prospective evaluation of a whole-blood test using mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin Diagn Lab Immunol 2005; 12: 491-496
8. Baba K, Sørnes S, Hoosen AA et al. Evaluation of immune responses in HIV infected patients with pleural tuberculosis by the QuantiFERON®TB-Gold interferon-gamma assay. BMC Infect Dis 2008; 8: 35-42
9. Inoue T, Nakamura T, Katagiri D et al. The usefulness of QuantiFERON®TB-2G for the diagnosis of tuberculosis in dialysis patients. J Jpn Soc Dial Ther 2008; 41: 65-70
10. Mazurek GH, Jereb J, Lobue P et al. Guidelines for using the QuantiFERON®TB-Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005; 54: 49-55
11. Resić H, Dizdarević Z, Corić A et al. Evaluation of clinical presentation and prognosis of tuberculosis in patients undergoing hemodialysis. Acta Med Croatica 2008; 62: 65-68
12. Kawabe Y. Application and problems of QuantiFERON®TB-2G for tuberculosis control programs - (2) clinical use of Quanti-FERON®TB-2G. Kekkaku 2007; 82: 61-66
13. Kobashi Y, Mouri K, Obase Y et al. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients. EurRespirJ 2007; 30: 945-950
14. Luetkemeyer AF, Charlebois ED, Flores LL et al. Comparison of an interferon-γ release assay with tuberculin skin testing in HIV-infected individuals. AmJ Respir Crit Care Med 2007; 175: 737-742
15. Ferrara G, Losi M, D'Amico R et al. Use in routine clinical practice of the two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006; 367: 1328-1334
16. Ferrara G, Losi M, Meacci M et al. Routine hospital use of a new commercial whole blood interferon-γ assay for the diagnosis of tuberculosis infection. AmJ Respir Crit Care Med 2005; 172: 631-635
17. Harada T, Sakata H, Yasumori R et al. Tuberculosis in patients undertaking hemodialysis. Kekkaku 1989; 64: 47-54
18. Kobashi Y, Mouri K, Yagi S et al. Clinical utility of the QuantiFERON TB-2G test for elderly patients with active tuberculosis. Chest 2008; 133: 1196-1202
19. Chee CBE, Gan SH, Khin Mar KW et al. Comparison of sensitivities of two commercial gamma interferon release assays for pulmonary tuberculosis. J Clin Microbiol 2008; 46: 1935-1940
20. Taskapan H, Utas C, Oymak FS et al. The outcome of tuberculosis in patients on chronic hemodialysis. Clin Nephrol 2000; 54: 134-137
21. Andrew OT, Schoenfeld PY, Hopewell PC et al. Tuberculosis in patients with end-stage renal disease. Am J Med 1980; 68: 59-65
22. Brock I, Ruhwald M, Lundgren B et al. Latent tuberculosis in HIV positive, diagnosed by the M. Tuberculosis specific interferon-γ test. Respir Res 2006; 7: 56-64
23. Kobashi Y, Fukuda M, Yoshida K et al. An indeterminate QuantiFERON TB-2G response for military tuberculosis, due to severe pancytopenia. J Infect Chemother 2007; 13: 414-417
24. Christopoulos AI, Diamantopoulos AA, Dimopoulos PA et al. Male-female differences in the risk of tuberculosis in dialysis patients. Int Urol Nephrol 2008
25. Brock I, Munk ME, Kok-Jensen A et al. Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int J Tuberc Lung Dis 2001; 5: 462-467
26. Harada N, Nakajima Y, Higuchi K et al. Screening for tuberculosis infection using whole-blood interferon-gamma and mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol 2006; 27: 442-448
27. Diel R, Loddenkemper R, Meywald-Walter K et al. Predictive value of a whole blood IFN-γ assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 2008; 177: 1164-1170